glucagon has been researched along with hg-9-91-01 in 1 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (hg-9-91-01) | Trials (hg-9-91-01) | Recent Studies (post-2010) (hg-9-91-01) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 19 | 0 | 19 |
Protein | Taxonomy | glucagon (IC50) | hg-9-91-01 (IC50) |
---|---|---|---|
Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | 0.92 | |
Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | 3.3678 | |
Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | 9.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birnbaum, MJ; Boudaba, N; Campbell, DG; Deak, M; Foretz, M; Göransson, O; Gourlay, R; Gray, NS; Kaestner, KH; Marion, A; Patel, K; Peggie, M; Sakamoto, K; Sutherland, C; Titchenell, P; Tournier, E; Viollet, B; Wan, M | 1 |
1 other study(ies) available for glucagon and hg-9-91-01
Article | Year |
---|---|
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
Topics: AMP-Activated Protein Kinases; Animals; Fasting; Gene Expression Regulation; Glucagon; Gluconeogenesis; Glucose; Hepatocytes; Hyperglycemia; Insulin; Liver; Male; Mice; Mice, Knockout; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction; Transcription Factors | 2014 |